The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy.

Albert Topf; Moritz Mirna; Bernhard Ohnewein; Peter Jirak; Kristen Kopp; Dzeneta Fejzic; Michael Haslinger; Lukas Motloch; Uta Hoppe; Alexander Berezin; Michael Lichtenauer

doi:10.3389/fcvm.2020.579567

The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy.

Albert Topf (First author), Moritz Mirna (Co-author), Bernhard Ohnewein, Peter Jirak (Co-author), Kristen Kopp (Co-author), Dzeneta Fejzic (Co-author), Michael Haslinger (Co-author), Lukas Motloch (Co-author), Uta Hoppe (Co-author), Alexander Berezin, Michael Lichtenauer^* (Last author)

^*Corresponding author for this work

Department of Internal Medicine II - Division of Cardiology

Research output: Contribution to journal › Review article › peer-review

18 Citations (Web of Science)

Original language	English
Pages (from-to)	579567
Journal	Frontiers in Cardiovascular Medicine
Volume	7
DOIs	https://doi.org/10.3389/fcvm.2020.579567
Publication status	Published - 2020

Keywords

REDUCED EJECTION FRACTION
ENDOTHELIAL PROGENITOR CELLS
MICRORNA SIGNATURES DIFFERENTIATE
SERUM URIC-ACID
CARDIOVASCULAR-DISEASE
MYOCARDIAL-INFARCTION
NATRIURETIC PEPTIDE
CARDIAC FIBROSIS
CARBOHYDRATE ANTIGEN-125
CIRCULATING MICRORNAS

Access to Document

10.3389/fcvm.2020.579567

Cite this

@article{609392ea234941de8d0a8077ca41bed8,

title = "The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy.",

keywords = "REDUCED EJECTION FRACTION, ENDOTHELIAL PROGENITOR CELLS, MICRORNA SIGNATURES DIFFERENTIATE, SERUM URIC-ACID, CARDIOVASCULAR-DISEASE, MYOCARDIAL-INFARCTION, NATRIURETIC PEPTIDE, CARDIAC FIBROSIS, CARBOHYDRATE ANTIGEN-125, CIRCULATING MICRORNAS",

author = "Albert Topf and Moritz Mirna and Bernhard Ohnewein and Peter Jirak and Kristen Kopp and Dzeneta Fejzic and Michael Haslinger and Lukas Motloch and Uta Hoppe and Alexander Berezin and Michael Lichtenauer",

note = "all but Berezin: Paracelsus Med Univ Salzburg, Dept Cardiol, Clin Internal Med 2, Salzburg, Austria; ",

year = "2020",

doi = "10.3389/fcvm.2020.579567",

language = "English",

volume = "7",

pages = "579567",

journal = "Frontiers in Cardiovascular Medicine",

issn = "2297-055X",

publisher = "Frontiers Media Sa",

}

TY - JOUR

T1 - The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy.

AU - Topf, Albert

AU - Mirna, Moritz

AU - Ohnewein, Bernhard

AU - Jirak, Peter

AU - Kopp, Kristen

AU - Fejzic, Dzeneta

AU - Haslinger, Michael

AU - Motloch, Lukas

AU - Hoppe, Uta

AU - Berezin, Alexander

AU - Lichtenauer, Michael

N1 - all but Berezin: Paracelsus Med Univ Salzburg, Dept Cardiol, Clin Internal Med 2, Salzburg, Austria;

PY - 2020

Y1 - 2020

KW - REDUCED EJECTION FRACTION

KW - ENDOTHELIAL PROGENITOR CELLS

KW - MICRORNA SIGNATURES DIFFERENTIATE

KW - SERUM URIC-ACID

KW - CARDIOVASCULAR-DISEASE

KW - MYOCARDIAL-INFARCTION

KW - NATRIURETIC PEPTIDE

KW - CARDIAC FIBROSIS

KW - CARBOHYDRATE ANTIGEN-125

KW - CIRCULATING MICRORNAS

U2 - 10.3389/fcvm.2020.579567

DO - 10.3389/fcvm.2020.579567

M3 - Review article

C2 - 33344515

SN - 2297-055X

VL - 7

SP - 579567

JO - Frontiers in Cardiovascular Medicine

JF - Frontiers in Cardiovascular Medicine

ER -